Detecting common mutations in MM patients through liquid biopsy
Biomarkers for acute myeloid leukemia (AML) – lessons from IL-2 immunotherapy with HDC
Why has the biobank project been a success and what is the future for it?
Regis Peffault de Latour
Smouldering myeloma: detection, risk stratification and defining a new standard of care
Aims and impacts of the 100,000 Genomes Project